Lets hope its more than ONE CENT. With the right biotech to market this will be way above that...If Ichim has it right...But that is what is TBD..Need to monetize that IP...If the CEO is content with one penny as an achievement then the shareholders are dooomed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.